Prevention of hospital-acquired infections by selective digestive decontamination

Surgical Infections

Volumn 12, Issue 3, 2011, Pages 221-229

  Reed II, R Lawrence ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFOTAXIME; CHLORHEXIDINE; COLISTIN; NEOMYCIN; NORFLOXACIN; POLYMYXIN B; TOBRAMYCIN; VANCOMYCIN;

ASEPSIS; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; HOSPITAL INFECTION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; SEDATION; SELECTIVE DIGESTIVE DECONTAMINATION; STOMACH MUCOSA; SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; CROSS INFECTION; GASTROINTESTINAL TRACT; HUMANS; INCIDENCE; INFECTION CONTROL;

EID: 80052751208     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.031     Document Type: Conference Paper

References (78)

1. Institute for Healthcare Improvement. Implement the Ventilator Bundle [1/29/2011]. Available at www.ihi.org/IHI/ Topics/CriticalCare/IntensiveCare/ Changes/Implementthe VentilatorBundle.htm
2. Institute for Healthcare Improvement. Implement the Ventilator Bundle: Daily Oral Care with Chlorhexidine. 2010 [1/ 30/2011]. Available at www.ihi.org/IHI/Topics/Critical Care/IntensiveCare/Changes/IndividualChanges/ DailyOral CarewithChlorhexidine.htm
3. Mayr VD, Dunser MW, Greil V, et al. Causes of death and determinants of outcome in critically ill patients. Crit Care 2006;10:R154.
4. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
5. Boyce JM, Pittet D. Guideline for Hand Hygiene in Health- Care Settings: Recommendations of the Healthcare Infection Control Practices. Centers for Disease Control and Prevention 2002 [updated October 25, 2002 and January 16, 2011]. Available at www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
6. Evans HL, Dellit TH, Chan J, et al. Effect of chlorhexidine whole-body bathing in hospital-acquired infections among trauma patients. Arch Surg 2010;145:240-246.
7. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple-organ failure: Generalized autodestructive inflammation? Arch Surg 1985;120:1109-1115.
8. Meakins JL, Wicklund B, Forse RA, McLean AP. The surgical intensive care unit: Current concepts in infection. Surg Clin North Am 1980;60:117-132.
9. Norton LW. Does drainage of intraabdominal pus reverse multiple organ failure? Am J Surg 1985;149:347-350.
10. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple-organfailure syndrome. Arch Surg 1986;121:196-208.
11. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
12. Pecora DV. A comparison of transtracheal aspiration with other methods of determining the bacterial flora of the lower respiratory tract. N Engl J Med 1963;269:664-666.
13. Hoeprich PD. Etiologic diagnosis of lower respiratory tract infections. Calif Med 1970;112:1-8.
14. Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961;265:1273-1278.
15. Brumfitt W, Willoughby ML, Bromley LL. An evaluation of sputum examination in chronic bronchitis. Lancet 1957;273: 1306-1309.
16. Lees AW, McNaught W. Bacteriology of lower-respiratorytract secretions, sputum, and upper-respiratory-tract secretions in 'normals' and chronic bronchitics. Lancet 1959;2: 1112-1115.
17. Kalinske RW, Parker RH, Brandt D, Hoeprich PD. Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med 1967;276:604-608.
18. Reidenberg JS, Laitman JT. Blowing bubbles: An aquatic adaptation that risks protection of the respiratory tract in humpback whales (Megaptera novaeangliae). Anat Rec 2007; 290:569-580.
19. Frazier WJ, Hall MW. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 2008;55: 647-668.
20. Tschoeke SK, Ertel W. Immunoparalysis after multiple trauma. Injury 2007;38:1346-1357.
21. Bauer AJ, Schwarz NT, Moore BA, et al. Ileus in critical illness: Mechanisms and management. Curr Opin Crit Care 2002;8:152-157.
22. Carlson GL, Dark P. Acute intestinal failure. Curr Opin Crit Care 2010;16:347-352.
23. Madl C, Druml W. Gastrointestinal disorders of the critically ill: Systemic consequences of ileus. Best Pract Res Clin Gastroenterol 2003;17:445-456.
24. Leibovitz A, Baumoehl Y, Steinberg D, Segal R. Biodynamics of biofilm formation on nasogastric tubes in elderly patients. Isr Med Assoc J 2005;7:428-430.
25. Muscedere J, Rewa O, McKechnie K, et al. Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: A systematic review and meta-analysis. Crit Care Med 2011; Apr 7 [epub ahead of print]
26. Cameron JL, Reynolds J, Zuidema GD. Aspiration in patients with tracheostomies. Surg Gynecol Obstet 1973;136:68-70.
27. du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: A frequent cause of postoperative colonisation of the airway. Lancet 1982;1:242-524.
28. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995;122:179-186.
29. Cook D, De Jonghe B, Brochard L, Brun-Buisson C. Influence of airway management on ventilator-associated pneumonia: Evidence from randomized trials. JAMA.1998;279:781-787.
30. Spray SB, Zuidema GD, Cameron JL. Aspiration pneumonia: Incidence of aspiration with endotracheal tubes. Am J Surg 1976;131:701-703.
31. Young PJ, Burchett K, Harvey I, Blunt MC. The prevention of pulmonary aspiration with control of tracheal wall pressure using a silicone cuff. Anaesth Intensive Care 2000;28: 660-665.
32. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993;19:256-264.
33. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866-869.
34. Heyland DK, Cook DJ, Marshall J, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:1249-1256.
35. Stoutenbeek CP, Van Saene HK, Miranda DR, Zandstra DF. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg 1983;34:209-221.
36. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 1984;10:185-192.
37. Idemyor V. Selective decontamination of the digestive tract in the intensive care unit. J Nat Med Assoc 1994;86:409, 416, 432.
38. de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
39. Daschner F. Emergence of resistance during selective decontamination of the digestive tract. Eur J Clin Microbiol Infect Dis 1992;11:1-3.
40. Blair P, Rowlands BJ, Lowry K, et al. Selective decontamination of the digestive tract: A stratified, randomized, prospective study in a mixed intensive care unit. Surgery 1991;110:303-309.
41. Markowsky SJ, Christie J. Pharmacoeconomics of selective decontamination of the digestive tract in intensive care patients: A US perspective. Pharmacoeconomics 1994;5: 361-366.
42. Gastinne H, Wolff M, Delatour F, et al. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med 1992;326:594-599.
43. Hammond JM, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992;340:5-9.
44. van Enckevort PJ, Zwaveling JH, Bottema JT, et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics 2001; 19:523-530.
45. van Saene HK, Stoutenbeek CP, Hart CA. Selective decontamination of the digestive tract (SDD) in intensive care patients: A critical evaluation of the clinical, bacteriological and epidemiological benefits. J Hosp Infect 1991;18:261-277.
46. Sun X, Wagner DP, Knaus WA. Does selective decontamination of the digestive tract reduce mortality for severely ill patients? Crit Care Med 1996;24:753-755.
47. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. BMJ 1993;307:525-532.
48. van Nieuwenhoven CA, Buskens E, van Tiel FH, Bonten MJ. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 2001;286:335-340.
49. Silvestri L, van Saene HK, Milanese M, Gregori D. Impact of selective decontamination of the digestive tract on fungal carriage and infection: Systematic review of randomized controlled trials. Intensive Care Med 2005;31:898-910.
50. Silvestri L, van Saene HK, Casarin A, et al. Impact of selective decontamination of the digestive tract on carriage and infection due to gram-negative and gram-positive bacteria: A systematic review of randomised controlled trials. Anaesth Intensive Care 2008;36:324-338.
51. Vandenbroucke-Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991;338:859-862.
52. Heyland DK, Cook DJ, Jaeschke R, et al. Selective decontamination of the digestive tract: An overview. Chest 1994; 105:1221-1229.
53. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections: A metaanalysis. Chest 1994;105:1101-1108.
54. D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomised controlled trials. BMJ 1998;316:1275-1285.
55. Safdar N, Said A, Lucey MR. The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: A systematic review and metaanalysis. Liver Transpl 2004;10:817-827.
56. Silvestri L, van Saene HK, Sarginson RE, Gullo A. Selective decontamination of the digestive tract and ventilatorassociated pneumonia: We cannot let misinformation go uncorrected. J Intensive Care Med 2007;22:181-182.
57. Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: Systematic review and meta-analysis. BMJ 2007;334:889.
58. Ulrich C, Harinck-de Weerd JE, Bakker NC, et al. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: A prospective randomized study. Intensive Care Med 1989;15:424-431.
59. Fox MA, Peterson S, Fabri BM, van Saene HK. Selective decontamination of the digestive tract in cardiac surgical patients. Crit Care Med 1991;19:1486-1490.
60. Rocha LA, Martin MJ, Pita S, et al. Prevention of nosocomialinfection in critically ill patients by selective decontamination of the digestive tract: A randomized, double blind, placebo-controlled study. Intensive Care Med 1992;18:398-404.
61. Silvestri L, van Saene HK, Weir I, Gullo A. Survival benefit of the full selective digestive decontamination regimen. J Crit Care 2009;24:474 e7-e14.
62. Liberati A, D'Amico R, Pifferi S, et al. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2009(4):CD000022.
63. DeRiso AJ 2nd, Ladowski JS, Dillon TA, et al. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996;109:1556-1561.
64. Segers P, Speekenbrink RG, Ubbink DT, et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: A randomized controlled trial. JAMA 2006;296: 2460-2466.
65. Houston S, Hougland P, Anderson JJ, et al. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002;11:567-570.
66. Genuit T, Bochicchio G, Napolitano LM, et al. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect 2001;2:5-18.
67. Bopp M, Darby M, Loftin KC, Broscious S. Effects of daily oral care with 0.12% chlorhexidine gluconate and a standard oral care protocol on the development of nosocomial pneumonia in intubated patients: A pilot study. J Dent Hyg 2006;80:9.
68. Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator- associated pneumonia. Am J Respir Crit Care Med 2006;173:1348-1355.
69. Fourrier F, Cau-Pottier E, Boutigny H, et al. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000;26:1239-1247.
70. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008;29:131-136.
71. Cabov T, Macan D, Husedzinovic I, et al. The impact of oral health and 0.2% chlorhexidine oral gel on the prevalence of nosocomial infections in surgical intensive-care patients: A randomized placebo-controlled study. Wien Klin Wochenschr 2010;122:397-404.
72. Bellissimo-Rodrigues F, Bellissimo-Rodrigues WT, Viana JM, et al. Effectiveness of oral rinse with chlorhexidine in preventing nosocomial respiratory tract infections among intensive care unit patients. Infect Control Hosp Epidemiol 2009;30:952-958.
73. Fourrier F, Dubois D, Pronnier P, et al. Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: A double-blind placebo-controlled multicenter study. Crit Care Med 2005; 33:1728-1735.
74. Panchabhai TS, Dangayach NS, Krishnan A, et al. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: An open-label randomized trial with 0.01% potassium permanganate as control. Chest 2009;135: 1150-1156.
75. Kola A, Gastmeier P. Efficacy of oral chlorhexidine in preventing lower respiratory tract infections: Meta-analysis of randomized controlled trials. J Hosp Infect 2007;66:207-216.
76. Pineda LA, Saliba RG, El Solh AA. Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: A meta-analysis. Crit Care 2006;10:R35.
77. Panchabhai TS, Dangayach NS. Oral cleansing with chlorhexidine to decrease the incidence of nosocomial pneumonia: Using the right concentration in the right place. Infect Control Hosp Epidemiol 2010;31:429.
78. Seguin P, Tanguy M, Laviolle B, et al. Effect of oropharyngeal decontamination by povidone-iodine on ventilatorassociated pneumonia in patients with head trauma. Crit Care Med 2006;34:1514-1519.